Literature DB >> 10537859

EFQM approach and the Dutch Quality Award.

U W Nabitz1, N S Klazinga.   

Abstract

Different approaches to improve quality are used in organizations delivering health care. Donabedian introduced structure, process and outcome, from which other approaches like self-assessment, accreditation, visitation, International Standards Organisation (ISO) and European Foundation for Quality Management (EFQM) can be aligned. The EFQM model is one such approach that has been adopted and adapted by the Dutch Institute for Quality Management. This article describes the background and progress relating to the use of the EFQM business excellence model within Dutch health care organizations. In addition the process for applying for the European Quality Award and the Dutch Quality Award are described in detail. Finally, the reader is enlightened regarding the work of the European ExPeRT research group who are promoting the use of quality models within health care.

Mesh:

Year:  1999        PMID: 10537859     DOI: 10.1108/09526869910261286

Source DB:  PubMed          Journal:  Int J Health Care Qual Assur Inc Leadersh Health Serv        ISSN: 1366-0756


  3 in total

1.  [Successful implementation of the EFQM management model at the Department of Ophthalmology in Graz].

Authors:  G Langmann; R Maier; A Theisl; H Bauer; U Klug; C Foussek; R Hödl; A Wedrich; W Gliebe
Journal:  Ophthalmologe       Date:  2011-04       Impact factor: 1.059

2.  Evaluation of physical activity programmes for the elderly - exploring the lessons from other sectors and examining the general characteristics of the programmes.

Authors:  Ana I Marques; Pedro Soares; Luísa Soares-Miranda; Carla Moreira; António Oliveira-Tavares; Paula Clara-Santos; Susana Vale; Rute Santos; Joana Carvalho
Journal:  BMC Res Notes       Date:  2011-09-26

3.  [Jury prize of the Austrian National Prize 2018 : 12 years European Foundation for Quality Management (EFQM) at the University Eye Clinic Graz].

Authors:  G Langmann; W Gliebe; E Granitz; A Kohlhofer; S Reinisch; D Ivastinovic; A Wedrich
Journal:  Ophthalmologe       Date:  2020-10-23       Impact factor: 1.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.